Moody National Bank Trust Division’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.01M | Sell |
83,566
-582
| -0.7% | -$15.2K | 0.17% | 111 |
|
|
2026
Q1 | $2.36M | Buy |
84,148
+2,096
| +3% | +$55.8K | 0.23% | 81 |
|
|
2025
Q4 | $2.04M | Sell |
82,052
-21,093
| -20% | -$532K | 0.2% | 97 |
|
|
2025
Q3 | $2.63M | Buy |
103,145
+1,730
| +2% | +$42.7K | 0.22% | 96 |
|
|
2025
Q2 | $2.46M | Buy |
101,415
+6,700
| +7% | +$156K | 0.22% | 88 |
|
|
2025
Q1 | $2.4M | Sell |
94,715
-3,017
| -3% | -$78.9K | 0.25% | 81 |
|
|
2024
Q4 | $2.59M | Sell |
97,732
-3,396
| -3% | -$92.1K | 0.27% | 71 |
|
|
2024
Q3 | $2.93M | Buy |
101,128
+10,117
| +11% | +$295K | 0.31% | 65 |
|
|
2024
Q2 | $2.55M | Buy |
91,011
+1,149
| +1% | +$31.6K | 0.2% | 64 |
|
|
2024
Q1 | $2.49M | Sell |
89,862
-6,083
| -6% | -$169K | 0.2% | 64 |
|
|
2023
Q4 | $2.76M | Sell |
95,945
-69,018
| -42% | -$2.09M | 0.22% | 60 |
|
|
2023
Q3 | $5.47M | Buy |
164,963
+12,991
| +9% | +$459K | 0.35% | 39 |
|
|
2023
Q2 | $5.57M | Buy |
151,972
+2,599
| +2% | +$101K | 0.38% | 33 |
|
|
2023
Q1 | $6.09M | Buy |
149,373
+543
| +0.4% | +$23.5K | 0.52% | 27 |
|
|
2022
Q4 | $7.63M | Buy |
148,830
+653
| +0.4% | +$31.3K | 0.66% | 16 |
|
|
2022
Q3 | $6.48M | Buy |
148,177
+6,079
| +4% | +$295K | 0.67% | 17 |
|
|
2022
Q2 | $7.45M | Sell |
142,098
-14,482
| -9% | -$738K | 0.79% | 11 |
|
|
2022
Q1 | $8.11M | Sell |
156,580
-13,162
| -8% | -$683K | 0.25% | 18 |
|
|
2021
Q4 | $10M | Sell |
169,742
-355,728
| -68% | -$17.6M | 0.3% | 17 |
|
|
2021
Q3 | $22.6M | Buy |
525,470
+1,500
| +0.3% | +$66.5K | 0.33% | 24 |
|
|
2021
Q2 | $20.5M | Buy |
523,970
+428
| +0.1% | +$16.6K | 0.42% | 27 |
|
|
2021
Q1 | $19M | Sell |
523,542
-612
| -0.1% | -$21.7K | 0.45% | 27 |
|
|
2020
Q4 | $19.3M | Sell |
524,154
-23,426
| -4% | -$859K | 0.49% | 26 |
|
|
2020
Q3 | $19.1M | Buy |
547,580
+1,837
| +0.3% | +$64.4K | 0.59% | 25 |
|
|
2020
Q2 | $16.9M | Buy |
545,743
+14,731
| +3% | +$500K | 0.53% | 24 |
|
|
2020
Q1 | $16.4M | Sell |
531,012
-4,272
| -0.8% | -$146K | 0.58% | 23 |
|
|
2019
Q4 | $19.9M | Buy |
535,284
+2,439
| +0.5% | +$86.9K | 0.53% | 23 |
|
|
2019
Q3 | $18.2M | Sell |
532,845
-6,412
| -1% | -$233K | 0.51% | 28 |
|
|
2019
Q2 | $22.2M | Buy |
539,257
+1,383
| +0.3% | +$54.9K | 0.63% | 16 |
|
|
2019
Q1 | $21.7M | Sell |
537,874
-5,828
| -1% | -$233K | 0.6% | 17 |
|
|
2018
Q4 | $22.5M | Buy |
543,702
+3,880
| +0.7% | +$161K | 0.64% | 15 |
|
|
2018
Q3 | $22.6M | Buy |
539,822
+437,700
| +429% | +$16.8M | 0.57% | 17 |
|
|
2018
Q2 | $3.52M | Sell |
102,122
-1,054
| -1% | -$36K | 0.17% | 9 |
|
|
2018
Q1 | $3.47M | Sell |
103,176
-1,096
| -1% | -$37.7K | 0.18% | 12 |
|
|
2017
Q4 | $3.58M | Hold |
104,272
| – | – | 0.17% | 10 |
|
|
2017
Q3 | $3.53M | Sell |
104,272
-17,890
| -15% | -$575K | 0.17% | 8 |
|
|
2017
Q2 | $3.89M | Hold |
122,162
| – | – | 0.19% | 8 |
|
|
2017
Q1 | $3.96M | Sell |
122,162
-3,847
| -3% | -$121K | 0.2% | 8 |
|
|
2016
Q4 | $3.88M | Hold |
126,009
| – | – | 0.19% | 10 |
|
|
2016
Q3 | $4.05M | Sell |
126,009
-274
| -0.2% | -$9.16K | 0.22% | 8 |
|
|
2016
Q2 | $4.22M | Buy |
126,283
+15,905
| +14% | +$508K | 0.24% | 7 |
|
|
2016
Q1 | $3.1M | Buy |
110,378
+28,356
| +35% | +$810K | 0.2% | 11 |
|
|
2015
Q4 | $2.51M | Sell |
82,022
-14,229
| -15% | -$448K | 0.19% | 15 |
|
|
2015
Q3 | $2.87M | Buy |
96,251
+448
| +0.5% | +$14.4K | 0.22% | 10 |
|
|
2015
Q2 | $3.05M | Buy |
95,803
+737
| +0.8% | +$24K | 0.23% | 10 |
|
|
2015
Q1 | $3.14M | Buy |
95,066
+727
| +0.8% | +$23.1K | 0.24% | 7 |
|
|
2014
Q4 | $2.79M | Sell |
94,339
-728
| -0.8% | -$20.9K | 0.19% | 11 |
|
|
2014
Q3 | $2.67M | Buy |
95,067
+479
| +0.5% | +$13.4K | 0.18% | 14 |
|
|
2014
Q2 | $2.66M | Sell |
94,588
-2,582
| -3% | -$73.6K | 0.18% | 14 |
|
|
2014
Q1 | $2.96M | Sell |
97,170
-211
| -0.2% | -$6.29K | 0.2% | 13 |
|
|
2013
Q4 | $2.83M | Sell |
97,381
-359
| -0.4% | -$10.4K | 0.19% | 13 |
|
|
2013
Q3 | $2.66M | Sell |
97,740
-816
| -0.8% | -$22.2K | 0.21% | 12 |
|
|
2013
Q2 | $2.62M | Buy |
+98,556
| New | +$2.72M | 0.2% | 12 |
|
Other funds holding PFE
AIM
CWP
DADC
WG
Moody National Bank Trust Division's PFE Position: Q2 2026 in Review
Moody National Bank Trust Division reduced its Pfizer (PFE) stake by 0.69% in Q2 2026, selling an estimated $15.2K and leaving 83,566 shares worth $2.01M. The position accounts for 0.17% of the portfolio, ranked #111.
Moody National Bank Trust Division first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $22.6M in Q3 2021. 902 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Moody National Bank Trust Division held 83,566 shares of Pfizer worth $2.01M as of Q2 2026.
- Moody National Bank Trust Division sold 582 Pfizer shares in Q2 2026, an estimated $15.2K.
- Pfizer made up 0.17% of Moody National Bank Trust Division's portfolio in Q2 2026, its #111 holding.
- Moody National Bank Trust Division first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Moody National Bank Trust Division's Pfizer position peaked at $22.6M in Q3 2021.
- 902 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Moody National Bank Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.